• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SMITHS HEALTHCARE MANUFACTURING S.A. DE C.V. CADD ADMINISTRATION SET; SET, ADMINISTRATION, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SMITHS HEALTHCARE MANUFACTURING S.A. DE C.V. CADD ADMINISTRATION SET; SET, ADMINISTRATION, INTRAVASCULAR Back to Search Results
Catalog Number 21-7022-24
Medical Device Problem Codes Complete Blockage (1094); Disconnection (1171)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 11/20/2025
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that the devices¿ tubing was disconnected.The reporter noted that when the patient woke up in the morning, the tubing had been found disconnected.The disconnection had occurred at the blue connector on the tubing from the pump.The pump had been alarming with a ¿downstream occlusion¿ message.The patient had been instructed to stop the pump and clamp the tubing.It had been explained that any tubing that became disconnected could not be reconnected.The patient had been instructed to contact the clinic for further instructions and had been reminded of the four-hour stop window.The patient had been unsure how long the pump had been disconnected during sleep.The clinic had been scheduled to open at 8:00 a.M., and the patient had stated an intention to arrive at that time but had been advised to call immediately due to the medication stop window.The spiros had remained connected to the administration set, which had caused the downstream occlusion alarm and prevented any leak after the disconnection.The event occurred while in use with a patient at the patient's home and the operator of the device was a health professional.Associated pump complaint documented on (b)(4).
 
Additional Manufacturer Narrative
H3: investigation including root cause analysis is in progress.A supplemental mdr will be filed as necessary in accordance with 21 cfr 803.56 when additional reportable information becomes available.
 
Additional Manufacturer Narrative
G1: correction.H3: the device history record of reported lot number 6125849 was reviewed, and it was confirmed that no non-conformities were reported during production.The quality inspection forms were reviewed, and it was observed that no defects were found, and the lot was released.Without the return of the samples a comprehensive failure investigation cannot be performed, and a probable cause cannot be determined.If the product is returned, the complaint will be reopened for further investigation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CADD ADMINISTRATION SET
Common Device Name
SET, ADMINISTRATION, INTRAVASCULAR
Manufacturer (Section D)
SMITHS HEALTHCARE MANUFACTURING S.A. DE C.V.
ave calidad no. 4, parque
tijuana
MX 
Manufacturer Contact
reed covert
6000 nathan lane north
minneapolis, MN 55442
2247062300
MDR Report Key23804238
Report Number3012307300-2025-13477
Device Sequence Number18069421
Product Code FPA
UDI-Device Identifier10610586019791
UDI-Public(01)10610586019791(17)300604(10)6125849
Combination Product (Y/N)N
Initial Reporter StateKS
Initial Reporter CountryUS
PMA/510(K) Number
K895046
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Distributor
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date (Section B) 12/29/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue Number21-7022-24
Device Lot Number6125849
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 11/24/2025
Supplement Date Received by Manufacturer12/18/2025
Initial Report FDA Received Date12/15/2025
Supplement Report FDA Received Date12/29/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured06/16/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-